Company Profiles

driven by the PitchBook Platform

Cellex

2002 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$2.27M LATEST DEAL AMOUNT
1 INVESTORS
Description

Provider of medical diagnostic tests. The company offers two versions of a real-time Neuraminidase Inhibitor assay, which is designed for influenza diagnosis and drug resistance detection.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
9700 Great Seneca Highway
Rockville, MD 20850
United States

+1 (301) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cellex’s full profile, request a free trial.

Cellex Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Mar-2011 $2.27M 00000 Completed Generating Revenue
4. Accelerator/Incubator 12-Aug-2010 00000 00000 Completed Generating Revenue
3. Accelerator/Incubator 06-Feb-2009 00000 00000 Completed Generating Revenue
2. Grant 15-Aug-2008 $964K Completed Generating Revenue
1. Grant 01-May-2005 $1.49M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Cellex Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Maryland Industrial Partnerships Accelerator/Incubator Minority 000 0000 000000 0

Cellex Executive Team (1)

Name Title Board
Seat
Contact
Info
X James Li Ph.D Chief Executive Officer
Questions or concerns about this profile? Reach out to website-support@pitchbook.com